InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-05-20 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2025-04-17 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2025-01-29 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2024-10-17 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
| 2024-09-16 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net revenue | $130.6M+17.8% | $110.8M+22.8% | $90.2M+1.9% | $88.6M+56.2% | $56.7M |
| Salaries and related costs | $461.9M+15.6% | $399.4M+13.0% | $353.4M+10.7% | $319.2M+14.6% | $278.5M |
| Rent, supplies, contract labor and other | $140.4M+18.1% | $118.9M+9.5% | $108.6M+6.1% | $102.4M+8.8% | $94.1M |
| Depreciation and amortization | $21.1M+18.0% | $17.9M+19.3% | $15.0M+7.3% | $13.9M | — |
| Provision for credit losses | $7.6M+10.6% | $6.9M+12.0% | $6.2M+11.2% | $5.5M+4.6% | $5.3M |
| Clinic closure costs - lease and other | $270K-93.8% | $4.4M+2388.6% | $175K+143.1% | $72K | — |
| Total operating cost | $631.3M+15.3% | $547.4M+13.3% | $483.3M+9.6% | $441.1M+16.7% | $377.8M |
| Gross profit | $149.7M+20.8% | $123.9M+2.0% | $121.5M+8.5% | $112.0M-4.4% | $117.2M |
| Corporate office costs | $69.3M+18.8% | $58.3M+12.2% | $52.0M+12.7% | $46.1M-0.9% | $46.5M |
| (Gain) loss on change in fair value of contingent earn-out consideration | -$6.2M-2951.1% | $219K-85.9% | $1.6M | — | — |
| Impairment of goodwill and other intangible assets | $0 | $0-100.0% | $17.5M+92.0% | $9.1M | $0 |
| Impairment on assets held for sale | $0-100.0% | $2.4M | $0 | — | — |
| Operating income | $86.7M+37.6% | $63.0M+24.7% | $50.5M-11.1% | $56.8M-19.6% | $70.6M |
| Interest expense, debt and other | -$9.5M-18.0% | -$8.0M+13.8% | -$9.3M-61.0% | -$5.8M-513.5% | -$942K |
| Interest income from investments | $105K-97.3% | $3.9M+4.4% | $3.8M | $0 | $0 |
| Change in revaluation of put-right liability | -$1.3M-1512.2% | -$82K-103.2% | $2.6M+51740.0% | -$5K | $0 |
| Equity in earnings of unconsolidated affiliate | $1.5M+45.7% | $1.0M+6.2% | $955K-18.7% | $1.2M+949.1% | $112K |
| Loss on sale of a partnership | -$123K | $0 | $0 | — | — |
| Relief funds | $0 | $0-100.0% | $467K | $0-100.0% | $4.6M |
| Other | $458K+28.3% | $357K-8.5% | $390K-54.6% | $859K+331.7% | $199K |
| Total other expense | -$8.9M-218.3% | -$2.8M-145.4% | -$1.1M+7.7% | -$1.2M | — |
| Income before taxes | $77.8M+29.2% | $60.2M+21.9% | $49.4M-11.1% | $55.6M-24.1% | $73.2M |
| Provision for income taxes | $19.8M+35.6% | $14.6M+20.2% | $12.2M-0.1% | $12.2M-20.4% | $15.3M |
| Net income | $58.0M+27.2% | $45.6M+22.5% | $37.2M-14.3% | $43.4M-25.1% | $57.9M |
| Redeemable non-controlling interest - temporary equity | -$13.8M-37.9% | -$10.0M-126.9% | -$4.4M+35.9% | -$6.9M+39.2% | -$11.4M |
| Non-controlling interest - permanent equity | -$4.6M-10.7% | -$4.1M+9.3% | -$4.6M-4.8% | -$4.3M+24.2% | -$5.7M |
| Net income attributable to non-controlling interest | -$18.4M-30.0% | -$14.2M-57.8% | -$9.0M+20.2% | -$11.2M+34.2% | -$17.1M |
| Net income attributable to USPH shareholders | $39.6M+26.0% | $31.4M+11.3% | $28.2M-12.2% | $32.2M-21.2% | $40.8M |
| Basic earnings per share attributable to USPH shareholders (in dollars per share) | $1K-22.8% | $2K+43.8% | $1K-43.1% | $2K-6.6% | $2K |
| Diluted earnings per share attributable to USPH shareholders (in dollars per share) | $1K-22.8% | $2K+43.8% | $1K-43.1% | $2K-6.6% | $2K |
| Basic earnings per share - weighted-average shares (in shares) | $15.2M+0.7% | $15.1M+6.2% | $14.2M | — | — |
| Shares used in computation - diluted (in shares) | $15.2M+0.7% | $15.1M+6.2% | $14.2M+9.3% | $13.0M+0.7% | $12.9M |
| Dividends declared per common share (in dollars per share) | $2K+2.3% | $2K+2.3% | $2K+4.9% | $2K+12.3% | $1K |
| Net Patient Revenue [Member] | |||||
| Net revenue | $130.6M+17.8% | $110.8M+22.8% | $90.2M+1.9% | $88.6M+56.2% | $56.7M |
| Other Revenue [Member] | |||||
| Net revenue | $130.6M+17.8% | $110.8M+22.8% | $90.2M+1.9% | $88.6M+56.2% | $56.7M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
PACS Group (PACS) Appoints Carey P. Hendrickson as Chief Financial Officer
Is U.S. Physical Therapy, Inc. (USPH) A Good Stock To Buy Now?
3 Cash-Producing Stocks Walking a Fine Line
U.S. Physical Therapy, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call Dates